A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
This research study, called ATTAIN-Hypertension, is investigating a new medication, orforglipron, for adults who have high blood pressure and are also overweight or living with obesity. The main goal is to find out if orforglipron is effective in lowering blood pressure and to check how safe it is for people to use. Participants will be randomly assigned to either receive the new medicine or a 'dummy' pill (placebo) that looks the same but contains no active drug. This is a common way to test new treatments, helping researchers understand the medicine's true effects. It's part of a larger research programme looking into orforglipron.
A colpo d'occhio
Di cosa tratta questo studio?
This study, known as ATTAIN-Hypertension, is a clinical trial focused on a new medicine called orforglipron (which has a code name LY3502970). The main purpose of this research is to see if orforglipron can help people who have high blood pressure, especially if they are also overweight or living with obesity. High blood pressure can lead to serious health problems like heart attacks and strokes, so finding effective treatments is very important.
Researchers want to understand two key things: first, if orforglipron actually works to lower blood pressure in this group of people (this is called its 'efficacy'), and second, whether it is safe to use and what side effects it might have (this is called its 'safety'). To do this, some people in the study will receive orforglipron, while others will receive a 'placebo', which looks identical but doesn't contain any active medicine. This allows doctors to compare the results and see if the new medicine is having a real effect.
This specific study is part of a bigger research effort investigating orforglipron. By participating, you would be helping medical science learn more about how to treat high blood pressure in people who also struggle with their weight, potentially leading to new treatment options in the future.
Punti chiave
- The study is testing a new medicine, orforglipron, for high blood pressure.
- It's for adults who also have obesity or are overweight.
- The goal is to check how well the medicine works and if it's safe.
- Some participants will get the actual medicine, others a dummy pill.
- Participation involves regular clinic visits and health checks.
- You can leave the study at any time if you change your mind.
Chi può essere idoneo?
To be considered for this study, you must be 18 years old or older. The study is open to both men and women.
Since this study is part of a larger research programme, there are specific guidelines that decide who can and cannot take part. These guidelines are carefully considered to make sure the study is safe for everyone involved and that the results are clear.
If you are interested, a member of the research team will explain these guidelines in detail and check if you meet all the necessary requirements for screening. They will ask questions about your health and medical history.
Questo studio potrebbe fare al caso tuo?
Rispondi a queste domande rapide per vedere se potresti essere idoneo. Questo è solo una guida — il team di ricerca prende la decisione finale.
- Hai 18 anni o più?
- Do you have high blood pressure?
- Are you currently overweight or living with obesity?
- Sei in grado di partecipare a appuntamenti clinici regolari?
Cosa comporta la partecipazione?
Taking part in this study would involve a series of visits to the clinic over a period of time. During these visits, you would have various health checks, such as measurements of your blood pressure, weight, and blood tests. You would be given either the study medicine (orforglipron) or a dummy pill (placebo) to take regularly, as instructed by the study team.
The specific number of visits and the total length of your participation would be explained fully by the study team during your initial conversations. There will also be follow-up appointments to monitor your health and how you are responding to the medication. All procedures, including medication doses and the duration of the study, will be carefully set out in the study plan.
Rischi e benefici potenziali
Locations (99)
- Elite Clinical Studies, LLCCodice postale verificatoPhoenix, Stati Uniti
- Valley Clinical Trials, Inc.Codice postale verificatoCovina, Stati Uniti
- Valley Clinical Trials, Inc.Codice postale verificatoNorthridge, United States
- Chase Medical Research, LLCCodice postale verificatoWaterbury, United States
- Excel Medical Clinical TrialsCodice postale verificatoBoca Raton, United States
- Care Access - BrandonCodice postale verificatoBrandon, United States
- Northeast Research Institute - Downtown OfficeCodice postale verificatoJacksonville, Stati Uniti
- Peace River Cardiovascular CenterCodice postale verificatoPort Charlotte, United States
- East-West Medical Research InstituteCodice postale verificatoHonolulu, United States
- Sinai Hospital Of BaltimoreCodice postale verificatoBaltimora, Stati Uniti
- Ascension Saint Agnes Heart CareCodice postale verificatoBaltimora, Stati Uniti
- Lucida Clinical TrialsCodice postale verificatoNew Bedford, United States
Domande comuni
Che cos'è l'ipertensione?
High blood pressure, or hypertension, means your blood is pushing too hard against the walls of your arteries. Over time, this can damage your blood vessels and lead to serious health problems like heart disease or stroke.
What is 'obesity or overweight' in this study?
This refers to having a body weight that is higher than what is considered healthy for your height. The study will use specific measurements, like Body Mass Index (BMI), to determine this.
What is a 'placebo'?
A placebo is a 'dummy' pill or treatment that looks exactly like the real medicine but contains no active drug. It helps researchers see if the real medicine is actually working or if improvements are due to other factors.
Sapró se sto ricevendo il vero medicinale o il placebo?
No, neither you nor the study team will know whether you are receiving the active medicine or the placebo. This is to ensure the study results are fair and unbiased. This is called 'blinding'.
Posso smettere di partecipare allo studio se lo desidero?
Yes, absolutely. Your participation is completely voluntary, and you can choose to leave the study at any time, for any reason, without it affecting your future medical care.
Come saperne di più
Parla sempre con il tuo medico di base o specialista prima di decidere di partecipare a uno studio.
Discussione
Discussione della comunità
Supportato dal nostro forum su community.patient.info. Si prega di essere rispettosi — questo non è un consiglio medico.